Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: hameln pharma plus gmbh, Langes Feld 13, 31789, Hameln, Germany
Clarithromycin 500 mg powder for concentrate for solution for infusion.
| Pharmaceutical Form |
|---|
|
Powder for concentrate for solution for infusion. White to off white cake lyophilized sterile powder for reconstitution and administration by intravenous infusion. |
Each vial contains 739.5 mg clarithromycin lactobionate, corresponding to 500 mg clarithromycin.
Excipient(s) with known effect: This medicinal product contains less than 1 mmol sodium (23 mg) per vial, that is to say essentially ‘sodium-free’.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Clarithromycin |
Clarithromycin is a semi-synthetic derivative of erythromycin A. It exerts its antibacterial action by selectively binding to the 50s ribosomal sub-unit of susceptible bacteria preventing translocation of activated amino acids. It inhibits the intracellular protein synthesis of susceptible bacteria. |
| List of Excipients |
|---|
|
Sodium hydroxide (pH adjuster) |
Uncoloured clear glass vial type I (15 ml), sealed with brombutyl rubber stopper and aluminium cap with plastic flip-off seal.
The following pack sizes are available for Clarithromycin 500 mg powder for concentrate for solution for infusion:
1, 5 or 10 vial(s) containing 500 mg of clarithromycin.
Not all pack sizes may be marketed.
hameln pharma plus gmbh, Langes Feld 13, 31789, Hameln, Germany
PL 25215/0033
16/05/2018
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
